GLP-1 receptors are present in the heart and blood cells, and activating these receptors has been associated with improved cardiac function, reduced inflammation, and decreased oxidative stress
Below is a clinically accurate overview of current FDA-approved GLP-1 receptor agonists in the United States, along with their delivery forms and labeled therapeutic uses
Overgaard RV, Hertz CL, Ingwersen SH, Navarria A, Drucker DJ
The downstream effects are what people actually care about
In Ireland, the $800 million Kinsale facility deploying a first-of-its-kind hybrid continuous manufacturing platform for complex peptides was formally unveiled in September 2024, already producing tirzepatide, alongside a $2 billion total investment in the Limerick biologics site for biologic active ingredient production